Sudeep Pharma Limited (NSE:SUDEEPPHRM)
India flag India · Delayed Price · Currency is INR
1,207.60
-0.10 (-0.01%)
Nov 12, 2026, 3:29 PM IST

Sudeep Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,8831,7291,3871,332623.21497.99
Depreciation & Amortization
170.27147.13104.9989.2178.2947.06
Other Amortization
0.960.960.920.920.89-
Loss (Gain) From Sale of Assets
-1-0.41-0.020.840.03
Loss (Gain) From Sale of Investments
-1.17-1.21-0.09-0.94-0.33-0.51
Provision & Write-off of Bad Debts
49.3658.035.96-3.0461.553.23
Other Operating Activities
-55.16-117.637817.1250.2319.95
Change in Accounts Receivable
-465.23-212.9-406.57-498.9179.02-517.42
Change in Inventory
-905.59-799.32-620.8844.15-344.62-190.67
Change in Accounts Payable
290.22-20.42105.85122.2479.88117.35
Change in Other Net Operating Assets
-12.81-88.04-168.61-445.99-145.01-3.4
Operating Cash Flow
953.25695.53487.27656.85483.95-26.39
Operating Cash Flow Growth
131.27%42.74%-25.82%35.73%--

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,342-853.78-642.33-499.86-471.53-577.54
Sale of Property, Plant & Equipment
1.93-3.40.590.40.36
Cash Acquisitions
--1,286----
Sale (Purchase) of Real Estate
-327.7-327.7--24.76--
Investment in Securities
-352.48-875.85-15030-30192.31
Other Investing Activities
55.3133.791.371.220.970.72
Investing Cash Flow
-1,965-3,309-787.56-492.8-500.16-384.15

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-145.51296.619.2233.37384.98
Long-Term Debt Issued
-7038010-205.38
Total Debt Issued
568.95215.51676.6119.2233.37590.36
Long-Term Debt Repaid
--112.6-95.42-108.97-84.65-66.44
Lease Payments
-9.11-9.11-9.15-3.35-2.82-2.43
Net Debt Issued (Repaid)
440.36102.91581.19-89.75-51.28523.92
Issuance of Common Stock
950950----
Other Financing Activities
-195.21-180.04-54.23-37.6-46.49-18.2
Financing Cash Flow
1,0262,473526.96-127.35-97.77505.72

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
3.962.81.640.052.26-
Miscellaneous Cash Flow Adjustments
-37.42----
Net Cash Flow
18.01-100.68228.3136.75-111.7295.18

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-388.76-158.25-155.0615712.42-603.93
Free Cash Flow Growth
---1164.05%--
Free Cash Flow Margin
-5.48%-2.46%-3.09%3.42%0.29%-17.52%
Free Cash Flow Per Share
-3.43-1.42-1.431.450.11-5.57
Levered Free Cash Flow
-874.74-739.67-493.92-161.13-168.82-
Unlevered Free Cash Flow
-824.83-695.29-459.8-137.26-140.18-
Free Cash Flow After Leases
-397.87-167.36-164.21153.659.6-606.36

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
128.57113.3954.2337.646.4918.2
Cash Income Tax Paid
584.69554.74405.5447.47224.2175.44
Change in Working Capital
-1,093-1,121-1,090-778.51-330.73-594.14